Vivos (RDGL) Cash & Equivalents (QoQ) (2010 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Vivos | - | - | -3,105.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -29.23% |
| Sep 30, 2025 | -17.23% |
| Jun 30, 2025 | -18.51% |
| Mar 31, 2025 | 47.57% |
| Dec 31, 2024 | 81.63% |
| Sep 30, 2024 | -29.36% |
| Jun 30, 2024 | 25.79% |
| Mar 31, 2024 | -13.91% |
| Dec 31, 2023 | 3.61% |
| Sep 30, 2023 | -12.12% |
| Jun 30, 2023 | 23.81% |
| Mar 31, 2023 | -17.21% |
| Dec 31, 2022 | -14.17% |
| Sep 30, 2022 | 89.18% |
| Jun 30, 2022 | -14.01% |
| Mar 31, 2022 | -23.93% |
| Dec 31, 2021 | -19.15% |
| Sep 30, 2021 | -8.23% |
| Jun 30, 2021 | -13.82% |
| Mar 31, 2021 | 177.95% |
| Dec 31, 2020 | 5,951.32% |
| Sep 30, 2020 | -94.00% |
| Dec 31, 2019 | -87.14% |
| Sep 30, 2019 | 1,764.71% |
| Jun 30, 2019 | -79.65% |
| Mar 31, 2019 | 660.63% |
| Mar 31, 2018 | -99.81% |
| Dec 31, 2017 | -62.38% |
| Sep 30, 2017 | -94.02% |
| Jun 30, 2017 | 1,458.86% |
| Mar 31, 2017 | -15.02% |
| Dec 31, 2016 | 185,826.67% |
| Sep 30, 2016 | -91.80% |
| Jun 30, 2016 | -99.93% |
| Mar 31, 2016 | 38.49% |
| Dec 31, 2015 | 2,320.66% |
| Sep 30, 2015 | -71.80% |
| Jun 30, 2015 | 955.57% |
| Mar 31, 2015 | 1,124.14% |
| Dec 31, 2014 | -61.33% |
| Sep 30, 2014 | -99.58% |
| Jun 30, 2014 | 36.67% |
| Sep 30, 2013 | 275.34% |
| Jun 30, 2013 | -89.65% |
| Mar 31, 2013 | 953.21% |
| Dec 31, 2012 | -86.47% |
| Sep 30, 2012 | 242.27% |
| Dec 31, 2011 | 181.78% |
| Sep 30, 2011 | 263.45% |
| Dec 31, 2010 | 6.01% |
| Sep 30, 2010 | 983.02% |